127 related articles for article (PubMed ID: 37658597)
21. Outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing robotic (RPD) or open pancreaticoduodenectomies (OPD): a propensity score-weighted survival analysis.
Mejia A; Shah J; Vivian E; Beard R; Acharya P; Gutierrez JCB
J Robot Surg; 2023 Jun; 17(3):1085-1096. PubMed ID: 36581740
[TBL] [Abstract][Full Text] [Related]
22. A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinoma.
Jamieson NB; Denley SM; Logue J; MacKenzie DJ; Foulis AK; Dickson EJ; Imrie CW; Carter R; McKay CJ; McMillan DC
Ann Surg Oncol; 2011 Aug; 18(8):2318-28. PubMed ID: 21267785
[TBL] [Abstract][Full Text] [Related]
23. Impact of adjuvant chemotherapy after pancreaticoduodenectomy for distal cholangiocarcinoma: a propensity score analysis from a French multicentric cohort.
Bergeat D; Turrini O; Courtin-Tanguy L; Truant S; Darnis B; Delpero JR; Mabrut JY; Regenet N; Sulpice L
Langenbecks Arch Surg; 2018 Sep; 403(6):701-709. PubMed ID: 30112638
[TBL] [Abstract][Full Text] [Related]
24. Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Assifi MM; Zhang S; Leiby BE; Pequignot EC; Xia B; Rosato E; Lavu H; Kennedy EP; Yeo CJ; Berger AC
J Am Coll Surg; 2013 Oct; 217(4):621-7. PubMed ID: 23810574
[TBL] [Abstract][Full Text] [Related]
25. Perioperative and Oncological Outcomes of Robotic Versus Open Pancreaticoduodenectomy in Low-Risk Surgical Candidates: A Multicenter Propensity Score-Matched Study.
Liu Q; Zhao Z; Zhang X; Wang W; Han B; Chen X; Tan X; Xu S; Zhao G; Gao Y; Gan Q; Yuan J; Ma Y; Dong Y; Liu Z; Wang H; Fan F; Liu J; Lau WY; Liu R
Ann Surg; 2023 Apr; 277(4):e864-e871. PubMed ID: 34417366
[TBL] [Abstract][Full Text] [Related]
26. Preoperative serum C-reactive protein levels and post-operative lymph node ratio are important predictors of survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Sanjay P; de Figueiredo RS; Leaver H; Ogston S; Kulli C; Polignano FM; Tait IS
JOP; 2012 Mar; 13(2):199-204. PubMed ID: 22406601
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
[TBL] [Abstract][Full Text] [Related]
28. Pancreaticoduodenectomy is justified in a subset of elderly patients with pancreatic ductal adenocarcinoma: A population-based retrospective cohort study of 4,283 patients.
Lu L; Zhang X; Tang G; Shang Y; Liu P; Wei Y; Gong P; Ma L
Int J Surg; 2018 May; 53():262-268. PubMed ID: 29604352
[TBL] [Abstract][Full Text] [Related]
29. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
[TBL] [Abstract][Full Text] [Related]
30. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?
Croome KP; Farnell MB; Que FG; Reid-Lombardo KM; Truty MJ; Nagorney DM; Kendrick ML
Ann Surg; 2014 Oct; 260(4):633-8; discussion 638-40. PubMed ID: 25203880
[TBL] [Abstract][Full Text] [Related]
31. The Results of Pancreatic Resections and Long-Term Survival for Pancreatic Ductal Adenocarcinoma: A Single-Institution Experience.
Seppänen H; Juuti A; Mustonen H; Haapamäki C; Nordling S; Carpelan-Holmström M; Sirén J; Luettges J; Haglund C; Kiviluoto T
Scand J Surg; 2017 Mar; 106(1):54-61. PubMed ID: 27130378
[TBL] [Abstract][Full Text] [Related]
32. Propensity score-matched comparison of the oncological feasibility and survival outcomes for pancreatic adenocarcinoma with robotic and open pancreatoduodenectomy.
Shyr BU; Shyr BS; Chen SC; Shyr YM; Wang SE
Surg Endosc; 2022 Feb; 36(2):1507-1514. PubMed ID: 33770276
[TBL] [Abstract][Full Text] [Related]
33. The true prognosis of resected distal cholangiocarcinoma.
Courtin-Tanguy L; Rayar M; Bergeat D; Merdrignac A; Harnoy Y; Boudjema K; Meunier B; Sulpice L
J Surg Oncol; 2016 Apr; 113(5):575-80. PubMed ID: 26776934
[TBL] [Abstract][Full Text] [Related]
34. Histologic Tumor Grade and Preoperative Bilary Drainage are the Unique Independent Prognostic Factors of Survival in Pancreatic Ductal Adenocarcinoma Patients After Pancreaticoduodenectomy.
Macías N; Sayagués JM; Esteban C; Iglesias M; González LM; Quiñones-Sampedro J; Gutiérrez ML; Corchete LA; Abad MM; Bengoechea O; Muñoz-Bellvis L
J Clin Gastroenterol; 2018 Feb; 52(2):e11-e17. PubMed ID: 28059940
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic versus open distal pancreatectomy for pancreatic ductal adenocarcinoma: a single-center propensity score matching study.
Chen K; Tong Q; Yan JF; Huang CJ; Pan Y; Zhang RC; Chen QL; Zheng XY; Cai XY; Wang Y; Wang XF
Updates Surg; 2020 Jun; 72(2):387-397. PubMed ID: 32266660
[TBL] [Abstract][Full Text] [Related]
36. Role of the lymph node ratio in pancreatic ductal adenocarcinoma. Impact on patient stratification and prognosis.
La Torre M; Cavallini M; Ramacciato G; Cosenza G; Rossi Del Monte S; Nigri G; Ferri M; Mercantini P; Ziparo V
J Surg Oncol; 2011 Nov; 104(6):629-33. PubMed ID: 21713779
[TBL] [Abstract][Full Text] [Related]
37. Pancreatic resections: 30 and 90-day outcomes in octogenarians.
Levi ST; Gough BL; Darcy CE; Petrelli NJ; Bennett JJ
Surg Oncol; 2021 Jun; 37():101319. PubMed ID: 34103239
[TBL] [Abstract][Full Text] [Related]
38. Cephalic pancreatoduodenectomy in octogenarian patients with pancreatic tumors.
Justo Alonso I; Alonso Murillo L; Marcacuzco Quinto A; Caso Maestro Ó; Rioja Conde P; Fernández C; Jiménez Romero C
Cir Esp (Engl Ed); 2023 Sep; 101(9):599-608. PubMed ID: 37541325
[TBL] [Abstract][Full Text] [Related]
39. The preoperative controlling nutritional status (CONUT) score is an independent prognostic marker for pancreatic ductal adenocarcinoma.
Terasaki F; Sugiura T; Okamura Y; Ito T; Yamamoto Y; Ashida R; Ohgi K; Uesaka K
Updates Surg; 2021 Feb; 73(1):251-259. PubMed ID: 32410163
[TBL] [Abstract][Full Text] [Related]
40. Short- and mid-term outcomes of robotic versus laparoscopic distal pancreatosplenectomy for pancreatic ductal adenocarcinoma: A retrospective propensity score-matched study.
Qu L; Zhiming Z; Xianglong T; Yuanxing G; Yong X; Rong L; Yee LW
Int J Surg; 2018 Jul; 55():81-86. PubMed ID: 29802919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]